We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vectura Group Plc | LSE:VEC | London | Ordinary Share | GB00BKM2MW97 | ORD 0.0271P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 164.80 | 164.80 | 165.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/3/2018 08:51 | Bad news (priced in several times over) would have been had FDA rejected it or HIK canned it. This is good news-just the mms mugging the impatient and the naive before market starts to look at the whole VEC business. Expect this to be 120 in no time (or 150 if there is a bid which is now more likely). | cumnor | |
12/3/2018 08:47 | cumnor, I am in... looks oversold here at these levels.... should have already been priced in... bought 4 tranches already this morning | cantrememberthis2 | |
12/3/2018 08:12 | Good news, and clarity, what VEC needs. A TO now more likely as well. | cumnor | |
12/3/2018 07:40 | This is better than expected.Share price should rise to 95p-100p | inv | |
12/3/2018 07:28 | Agreed. Could have been canned which would have been much worse. | snape | |
12/3/2018 07:26 | Dip rise I think | richtea2517 | |
12/3/2018 07:18 | Not good news, unfortunately, but at least we have some clarity. It looks like another 18 months or so before we know whether the generic will be approved. Vec are putting a positive spin on, only to be expected. I hope this result was in the price already. | alexchry | |
11/3/2018 09:27 | That should stir some interest tomorrow.Hikma report this week and Vectura the following week.Good news on Advair copy would be the icing on the cake. | fhmktg | |
11/3/2018 08:11 | Copycat drug makers on alert as Germany's Stada eyes acquisition spree "Mr Albrecht was tight-lipped on a UK target but City analysts suggested that beleaguered London-listed firms Vectura and Hikma could fit the bill – two companies developing generic drugs, products with expired patents." | kamitora | |
09/3/2018 16:26 | Looking like a great little bowl. Maybe needs to confirm support at 80p. | brucie5 | |
09/3/2018 15:58 | It doesn't seem all that long ago that I was looking for 180 to be broken! It's a long way back but maybe, just maybe... | gbcol | |
09/3/2018 14:55 | 80 about to be broken? | brucie5 | |
09/3/2018 14:16 | Rathean, agreed. I bought some of these at higher levels for my daughter's ISA and they've done terribly. But just bought some for myself at .79 as I believe they are likely to be oversold, and the last rally took them to 1.20. I will be trading these though, and have placed a sell limit. Looks decent odds to me for 20% at least. The tech here is well established and it's a mystery to me why it's done so badly since the merger. | brucie5 | |
09/3/2018 10:00 | Interesting, if we finish above 80p I don't see any other ceiling until 120p. Definitely plenty of support at low 70s so I guess I narrow sideways trading range until results or GSK 100 billion bid for VEC :) | rathean | |
08/3/2018 11:38 | I'm not sure there is any conspiracy going on regarding a takeover although the fall in share price over the past year must make them more of a target. Vec have lost around 50% of their value in the past year and Hikma have lost around 60%, even GSK have lost 20% so it may just be that pharma stocks are weak at the moment. Vec and Hikma have the worries of Advair and the FDA to contend with which may account for their extra large fall. | alexchry | |
08/3/2018 11:13 | It certainly looks like the share price is being softened up prior to a takeover approach. However, its multiple partnerings would make this very complicated for many other companies in the same sector so perhaps we should be thinking in terms of private equity or a conglomerate group with spare cash. | boadicea | |
08/3/2018 10:51 | Vectura Group Plc : Investec cuts target price to 147p from 152p * | muffster | |
08/3/2018 10:44 | Just added... Not seen such bot trading like this, appears manipulated | muffster | |
07/3/2018 17:01 | Eastbourne 1982... well said :) | dontay | |
07/3/2018 16:56 | It was up by 5 - 6% yesterday, was good news coming 24 hours ago ? | eastbourne1982 | |
07/3/2018 16:43 | 7% down on high volume suggests a leak somewhere.Eyes peeled for bad news coming | fhmktg | |
07/3/2018 16:23 | £250K buy this morning. Shorters toying with this | justiceforthemany | |
07/3/2018 13:18 | some how i don't think it's me ,but this is being worked big time . Ps am away again in 7 weeks if that helps !!! | pooroldboy55 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions